1245.33 a phase 11b, randomised, double-blind, placebo controlled, parallel group, safety and efficacy study of B1 10773 (10mg and 25mg) administered orally, once daily over 78 weeks in type 2 diabetic patients receiving once – daily treatment with basal insulin (glargine or detemir of NPH insulin only) with or without concomitant metformin and or sulfonylurea therapy and insufficient glycaemic control

Hdl Handle:
http://hdl.handle.net/10147/142436
Title:
1245.33 a phase 11b, randomised, double-blind, placebo controlled, parallel group, safety and efficacy study of B1 10773 (10mg and 25mg) administered orally, once daily over 78 weeks in type 2 diabetic patients receiving once – daily treatment with basal insulin (glargine or detemir of NPH insulin only) with or without concomitant metformin and or sulfonylurea therapy and insufficient glycaemic control
Authors:
Roberts, Graham Dr.
Affiliation:
Waterford Regional Hospital
Issue Date:
8-Feb-2010
URI:
http://hdl.handle.net/10147/142436
Item Type:
Other
Language:
en
Description:
Trial closed.
Keywords:
DIABETES MELLITUS

Full metadata record

DC FieldValue Language
dc.contributor.authorRoberts, Graham Dr.en
dc.date.accessioned2011-09-16T10:21:17Z-
dc.date.available2011-09-16T10:21:17Z-
dc.date.issued2010-02-08-
dc.identifier.urihttp://hdl.handle.net/10147/142436-
dc.descriptionTrial closed.en
dc.languageeng-
dc.language.isoenen
dc.subjectDIABETES MELLITUSen
dc.title1245.33 a phase 11b, randomised, double-blind, placebo controlled, parallel group, safety and efficacy study of B1 10773 (10mg and 25mg) administered orally, once daily over 78 weeks in type 2 diabetic patients receiving once – daily treatment with basal insulin (glargine or detemir of NPH insulin only) with or without concomitant metformin and or sulfonylurea therapy and insufficient glycaemic controlen
dc.typeOtheren
dc.contributor.departmentWaterford Regional Hospitalen
dc.description.provinceMunster-
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.